Диссертация (1146661), страница 16
Текст из файла (страница 16)
51.–P. 1578-1582.55.Chertow G.M., Jacobs D.O., Lazarus J.M. et al. Phase angle predicts survival inhemodialysis patients // J. Ren. Nutr.–1997.–Vol. 7.–P. 204-207.56. Chertow G.M., Ackert K., Lew N.L. et al. Prealbumin is as important as albuminin the nutritional assessment of hemodialysis patients // Kidney Int.–2000.–Vol.58, № 6.–P. 2512-2517.57.Chou C.C., Bai C.H., Tsai S.C., Wu M.S.
Low serum acylated ghrelin levels areassociated with the development of cardiovascular disease in hemodialysispatients// Intern Med. 2010;49(19): Р.2057-64.58.Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI,National Kidney Foundation, 2000.59.Cohn S.H., Brenna B.L., Yasumura S. et al. Evaluation of body composition andnitrogen content of renal patients on chronic dialysis as determined by total bodyneutron activation // Am. J.
Nephrol.–1983.–Vol. 38, № 1.–P. 52-58.11460.Collins A.J., Ma J.Z., Umen A., Keshaviah P. Urea index and other predictors ofhemodialysis patients survival // Am. J. Kidney Dis.–1993.–Vol. 23, № 2.–P.272-282.61.Cooper B.A., Bartlett L.H., Aslani A. et al. Validity of subjective globalassessment as a nutritional market in end-stage renal disease // Am. J. KidneyDis.–2002.–Vol.
40.–P. 126-132.62.Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology andPrevention// Cancer Res. 1992 Dec 15;52(24):6735-40.63.Coskun C., Kural A., Döventas Y., Koldas M., Ozturk H., Inal B.B., Gümüs A.Hemodialysis and protein oxidation products.// Ann N Y Acad Sci. 2007Apr;1100:404-8.64.Daugirdas J.T.
Simplified equations for monitoring Kt/v, PСRn, eKt/v,andePСRn // Adv. Ren Replace Ther.–1995.–Vol. 2.–P. 295 – 304.65.Date Y., Kojima M., Hosoda H. Ghrelin, a novel growth hormone-releasingacylated peptide, is synthesized in a distinct endocrine cell type in thegastrointestinal tracts of rats and humans.// Endocrinology. 2000 Nov;141(11):Р.4255-61.66.Deboer M.D., Zhu X., Levasseur P.R., Inui A. et al.
Ghrelin treatment of chronickidney disease: improvements in lean body mass and cytokine profile //Endocrinology 2008; 149 (2): Р.827-835.67.Delege M.H., Kirby D.F. Nutrition and renal disease // Practical Handbook ofNutrition in Clinical Practice / Kirby D.F., Dudrick S.J. – CRC Press: Boca RatinAnn Arbor-London-Tokyo, 1994.-P. 197-214.68.DeFronzo R.A., Alvestrand A., Smith D. et al. Insulin resistance in uremia // J.Clin. Invest.–1981.–Vol.67, № 2.–P.
563-568.11569. Dixon M.F. Prospects for intervention in gastric carcinogenesis: reversibility ofgastric atrophy and intestinal metaplasia. Gut. 2001 Jul;49(1):Р.2-4.70.Don B.R., Rosales L.M., Levine N.W. et al. Leptin is a negative acute phaseprotein in chronic hemodialysis patients // Kidney Int.–2001.–Vol. 59.–P. 11141120.71.Druml W.
Malnutrition is bad, but how can one detect malnutrition? // Nephrol.Dial. Transplant.-1997.–Vol. 12, № 11.–P. 2225-2227.72.Elsayed N.M., Hamed S.T., El-Khatib M.M., El-Shehaby A.M. The relationbetween dual energy x-ray absorptiometry measurement of body fat compositionand plasma ghrelin in patients with end-stage renal disease// Saudi Med J. 2009Jan;30(1): Р.109-15.73.European best practice guidelines on haemodialysis // Nephrol.
Dial.Transplant.–2007.–Vol. 22, suppl.2.–P. 45–87.74.Fain J.N., Madan A.K., Hiler M.L. et al. Comparison of the release of adipokinesby adipose tissue, adipose tissue matrix, and adipocytes from visceral andsubcutaneous abdominal adipose tissue of obese humans // Endocrinology.–2004.–Vol. 145.–P. 2273-2282.75.FAO/WHO. Energy and protein requirement // Report of a Joint FAO/WHO adhoc Expert Committee. WHO.
Techn. Rep. Ser. № 522. Geneva, 1973.–P. 61-64.76.Fatima A., Andrabi S., Wolf G., Engelmann M., Spina M.G. Urocortin 1administered into the hypothalamic supraoptic nucleus inhibits food intake infreely fed and food-deprived rats // Amino Acids. 2013 Mar;44(3): Р.879-85.77.Foley R.N., Parfrey P.S., Hamett J.D. et al. The impact of anemia oncardiomyopathy, morbidity, and mortality in end-stage renal disease // Am. J.Kidney Dis.–1996.–Vol.
28.–P. 53-61.78.Fouque D., Vennegoor M., ter Wee P. et al. EBPG guideline on nutrition.//Nephrol Dial Transplant. 2007 May;22 Suppl 2:ii45-87.11679.Fruhbeck G., Jebb S.A., Prentice A.M. Leptin: physiology and pathophysiology(Review) // Clinical physiology (Oxford).–1998.–Vol.18, № 5.–P. 399-419.80.Garber A.J. Effects of paraphyroid hormone on skeletal muscle protein andamino acid metabolism in the rat // J. Clin.
Invest.–1983.–Vol. 71, № 6.–P. 18061821.81.Garidotto G. Muscle amino acid metabolism and the control of muscle proteinturnover in patients with chronic renal failure // Nutrition.-1999.-Vol. 15, № 2.P. 145-155.82.Gilmour E.R., Hartley G.H., Goodship T.H.J. Trace elements vitamins in renaldisease // Nutrition and the Kidney / Mitch W.E., Klahr S.–Boston : Little, Brownand Co., 1993.–P. 114-131.83.Giemsa G. Eine Vereinfachung und Vervollkommnung meiner MethylenazurMethylenblau-Eosin-Färbemethode zur Erzielung der Romanowsky-NochtschenChromatinfärbung.
1904, Centralbl f Bakt etc 37: P.308–311.84.Gokal R. Quality of life in patients on replacement therapy of chronic renalfailure // Kidney Int.–1993.–Vol. 43, Suppl.40.–P. 23-27.85.Goldwasser P., Michel M.A., Collier S. et al. Prealbumin and lipoprotein (a) inhemodialysis: Relationships with patients and vascular access survival // Am. J.Kidney Dis.–1993.–Vol. 22, № 1.–P. 215-225.86.Graf L., Candelaria S., Doyle M,. Kaskel F. Nutrition assessment and hormonalinfluences on body composition in children with chronic kidney disease// AdvChronic Kidney Dis.
2007 Apr;14(2): Р.215-23.87.Grzegorzewska A. Protein catabolic rate (PCR), dietary protein intake (DPI) andmetabolic acidosis// Nephrol Dial Transplant. 1999 Sep;14(9):Р.2266-7.88.Guarnieri G., Toigo G., Fiotti N. et al. Mechanisms of malnutrition in uremia //Kidney Int.–1997.–Vol. 52, Suppl. 62.–P. S-41-S-44.11789. Guebre-Egziabher F, Bernhard J, Geelen G. Leptin, Adiponectin, and GhrelinDysregulation in Chronic Kidney Disease // J Renal Nutrition 2005; 15 (1):Р.116-120.90.Hakim R.M., Levin M. Malnutrition in hemodialysis patients // Am. J. KidneyDis.–1993.–Vol. 21.–P. 125-137.91.Heaf J. Adynamic bone disease and malnutrition-inflammation-cachexiasyndrome.// Kidney Int.
2007 Jun;71(12): Р.1326.92.Hirako M., Kamiya T., Misu N. et al. Impaired gastric motility and itsrelationship to gastrointestinal symptoms in patients with chronic renal failure//J Gastroenterol. 2005 Dec;40(12): Р.1116-22.93.Holland D.C., Meers C., Lawlor M.E., Lam M. Serial prealbumin levels aspredictors of outcomes in a retrospective cohort of peritoneal and hemodialysispatients // J. Ren. Nutr.–2001.–Vol. 11.–P. 129-138.94.Jacob V., Le Carpentier J.E., Salzano S.
et al. IGF-1 a marker of undernutritionin hemodialysis patients // Am. J. Clin. Nutr.–1990.–Vol. 52, № 1.–P. 39-4495.Jarkovska Z., Rosicka M., Krsek M., Sulkova S. et al. Plasma ghrelin levels inpatiens with End-Stage Renal Disease // Phisiological Research 2005 54: Р.403408.96.Jobst E., Enriori P., Cowley M. The electrophysiology of feeding circuits. Trends// Endocrinology Metab 2004; 15: Р.488-499.97.Johansen K.L., Mulligan K., Schambelan M. Anabolic effects of nandrolonedecanoate in patients receiving hemodialysis // J.
Am. Med. Assoc.–1999.–Vol.281, № 14.–P. 1275-1281.98.Joint WHO/FAO Expert Consultation on Diet, Nutrition and the Prevention ofChronic Diseases. Diet, nutrition and the prevention of chronic diseases: reportof a joint WHO/FAO expert consultation // Geneva, Switzerland: World HealthOrganization.–2003.11899.Ikizler T.A., Wingard R.L., Sun M. et al. Increased energy expenditure inhemodialysis patients // J. Am. Soc. Nephrol.–1996.–Vol. 7.–P. 2646-2653.100.
Ikizler T.A., Hakim R.M. Nutrition in end-stage renal disease // Kidney Int.–1996.–Vol. 50, № 2.–P. 343-357.101. Ingenbleek Y., Bernstein L. The stressful condition as a nutritionallydependent adaptive dichomony // Nutrition.–1999.–Vol. 25, № 4.–P. 305-320.102. Iseki K., Kawazoe N., Fukiyama K. Serum albumin is a strong predictor ofdeath in chronic dialysis patients // Kidney Int.–1993.–Vol.
44, № 1.–P. 115-119.103. Ishimura E., Okuno S., Kim M. et al. Increasing body fat mass in the first yearhemodialysis // J. Am. Soc. Nephrol.–2001.–Vol. 12, № 9.–P. 1921-1926.104.Iwabuchi H., Matsuzaki K. The treatment of peptic ulcer in elderly CRFpatients// Nihon Rinsho. 2002 Aug;60(8):Р.1601-5.105. Kalender B., Ozdemir A.C., Yalug I., Dervisoglu E. Antidepressant treatmentincreases quality of life in patients with chronic renal failure.// Ren Fail. 2007;29(7): Р.817-22.106.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
